Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of mild traumatic brain injury (mTBI) within the past 15 months~* Suffer at least fifteen total headache days per month~* Ability to speak and read English~Exclusion Criteria:~* Subject with hypersensitivity reactions or other intolerance to OnabotulinumtoxinA~* Previous use of OnabotulinumtoxinA for treatment of headache~* Any medications commonly used as headache preventives started less than 3 months prior to enrollment~* Prior or current diagnosis of major psychiatric disorder or other central nervous system disorder~* Less than 80% compliance (recorded for less than 24 days) in the 30 day screening headache diary~* Subjects who are pregnant or trying to become pregnant within the timeframe of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Treatment with OnabotulinumtoxinA (Type: EXPERIMENTAL): OnabotulinumtoxinA

Based on this trial design, predict the completion outcome and termination type (if applicable).